Navigation Links
Pharmacyclics Reports Fourth Quarter and Full Year Fiscal 2012 Financial Results and Recent Developments
Date:9/5/2012

12,329Other current assets9,7882,367Total current assets213,395114,696Property and equipment, net3,8421,312Other assets1,883344Total assets

$

219,120

$

116,352LIABILITIES AND STOCKHOLDERS' EQUITYDeferred revenue – current portion

$

8,054

$

7,000Other current liabilities10,9327,268Total current liabilities18,98614,268Deferred revenue – non-current portion67,324-Deferred rent687410Total liabilities86,99714,678Stockholders' equity132,123101,674Total liabilities and stockholders' equity

$

219,120

$

116,352* Marketable securities

$

5,711

$

24,572 Pharmacyclics, Inc.Condensed Consolidated Statements of Operations(unaudited; in thousands, except per share data) 

Three Months EndedJune 30, 

Year EndedJune 30,2012201120122011Revenue:License and milestone revenue

$

-

$

227

$

77,605

$

4,355Collaboration services revenue2,1231,1594,3853,878Total revenue2,1231,38681,9908,233Operating expenses*:Research and development15,3859,87554,53734,482General and administrative4,2202,50615,5759,125Total operating expenses19,60512,38170,11243,607(Loss) income from operations(17,482)(10,995)11,878(35,374)Interest and other income, net4731147171(Loss) income before income taxes(17,435)(10,964)12,025(35,203)Income tax benefit (provision)529-(39)-Net income (loss)

$

(16,906)

$

(10,964)

$

11,986

$

(35,203)Net income (loss) per share:Basic

$

(0.24)

$

(0.18)

$

0.17

$

(0.59)Diluted

$

(0.24)

$

(0.18)

$

0.17

$

(0.59)Weighted average shares used to compute net income (loss) per share:Basic 69,08160,96868,72859,973Diluted69,08160,96872,6
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
2. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
3. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
4. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
5. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
6. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
7. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
8. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
9. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
10. Luminex Corporation Reports First Quarter 2012 Results
11. Hospira Reports First-Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... VANCOUVER, British Columbia and ... DelMar Pharmaceuticals, Inc. (OTCQX: ... focused on developing and commercializing proven cancer therapies ... data at the American Association of Cancer ... on the potential for its lead product ...
(Date:5/29/2015)...  Eli Lilly and Company (NYSE: LLY ) ... they have entered into a clinical trial collaboration to ... anti-PD-L1 immune checkpoint inhibitor, MEDI4736, in combination with CYRAMZA ... medicine. The planned study will assess the combination as ... The Phase I study is expected to establish ...
(Date:5/29/2015)... 2015  World-renowned prostate surgeon and New York Urologist, Dr. ... of MR/Ultrasound Fusion-Guided Biopsy for detecting aggressive ... Center at Lenox Hill Hospital is the only center ... New York City . We,ve seen tremendous improvement ... The use of an MRI makes for a much more ...
Breaking Medicine Technology:DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 2DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 3DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 4DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 5Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 2Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 3Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 4Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 5Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 6Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 7Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 8Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 9Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 10Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 11Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 12Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 13Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 14MR/Ultrasound Fusion-Guided Biopsy Better Able to Detect Aggressive Prostate Cancer, New Study Says 2
... UK pharma group GlaxoSmithKline reports a 2% ... underlying sales momentum. In an interview with ... CFO Simon Dingemans review Q2 results including overall delivery ... a review of the recently implemented Drug Performance Units. ...
... Pharmaceuticals, Inc. announced the following news today concerning the future ... On December 31, 2011, the FDA ban ... a propellant will become effective. Primatene® Mist has ... symptoms for over 40 years. The ban on the sale ...
Cached Medicine Technology:Statement on Availability of Primatene® Mist CFC 2
(Date:5/30/2015)... 2015 The IRS released an ... that, “criminals used taxpayer-specific data acquired from non-IRS sources ... tax accounts through IRS’ “Get Transcript” application. This data ... address.” , “You don’t even have to be ... it was only a matter of time, especially after ...
(Date:5/29/2015)... May 30, 2015 “In the ... local and federal regulations, we provide education that ... patients who are suffering from pain, within the ... Nalamachu, MD, professor of rehabilitation medicine and President/Medical ... Overland Park, Kansas. , A new flight of ...
(Date:5/29/2015)... Tallahassee, FL (PRWEB) May 29, 2015 Ready ... trip, it’s important for all drivers to get their vehicles ... do to be prepared. Advanced Driving Systems (ADS) is ready ... some tips on preparing for summer road trips. , When ... do the following to ensure that the trip goes smoothly ...
(Date:5/29/2015)... May 29, 2015 The science of ... Los Angeles thanks to the efforts of internationally recognized ... has combined ARTAS hair restoration and manual ... restoration procedures available anywhere. , A Follicular Unit ... individually harvesting hair follicle grafts from the donor areas ...
(Date:5/29/2015)... Island (PRWEB) May 29, 2015 The ... 2015. The event, now closed to new registration, starts ... Adams. This exciting competitive running event demonstrates the ... to create a public benefit – in this case, ... coastal views around the famed Ocean Drive and passes ...
Breaking Medicine News(10 mins):Health News:IRS Attack Exemplifies the Compounding Dangers of Stolen Personal Data 2Health News:IRS Attack Exemplifies the Compounding Dangers of Stolen Personal Data 3Health News:IRS Attack Exemplifies the Compounding Dangers of Stolen Personal Data 4Health News:IRS Attack Exemplifies the Compounding Dangers of Stolen Personal Data 5Health News:PAINWeekEnd Kansas City: Pain Management CME for the Main Street Practitioner 2Health News:Advanced Driving Systems Offers Tips for Summer Road Trips 2Health News:Advanced Driving Systems Offers Tips for Summer Road Trips 3Health News:Los Angeles and Beverly Hills Hair Transplant Doctor Now Combines Robotic Hair Restoration (ARTAS) and Manual FUE Transplants for Maximum Hair Coverage 2Health News:The Newport 10 Miler at Fort Adams, an Outstanding Example of Event Marketing Helping in Preservation, is Now Completely Booked for 2015 2Health News:The Newport 10 Miler at Fort Adams, an Outstanding Example of Event Marketing Helping in Preservation, is Now Completely Booked for 2015 3
... of the communicable diseases in the country, according to ... Health and Family Welfare//. The news report was released ... a village near Vriddachalam. Chidambaram MP, E Ponnusamy, MLAs ... function. ,As many as 60 government doctors, ...
... UNICEF would collaborate on spreading awareness regarding the transmission ... spreading awareness to young people the dangers of HIV ... as children’s and young people are more attracted towards ... Understanding was signed in Delhi in the presence of ...
... is an idiopathic inflammatory disorder of the ... remain incompletely understood, many experimental and clinical ... in its pathogenesis//. ,In genetically ... failure of normal regulatory constraints on the ...
... of Delaware have developed a unique nanobomb that can ... more specifically breast cancer cells//. ,This latest attack ... and Oncology Issues by Balaji Panchapakesan, assistant professor of ... that the nanobomb technology is still in its infancy ...
... Immunodeficiency Virus type 1 (HIV-1) infection has improved ... 1996//. More recently, new drugs have been approved, ... while some previously popular drugs are being used ... Resistance testing is used more commonly in clinical ...
... have found an active gene in the legs of fleas, ... the flea to jump and leap at incredible heights and ... an incredible speed of 200 times/second. , ,Scientists have ... cultured them in the bacteria E.coli and found that it ...
Cached Medicine News:Health News:Non-Communicable Diseases Mounting Up At An Alarming Rate in India 2Health News:Indian Olympic Association And UNICEF To Collaborate On HIV/AIDS Awareness 2Health News:Bifidogenic Growth Stimulator: A Non-Toxic Way To Treat Ulcerative Colitis 2Health News:Simplest therapeutic regimen found less effective against HIV 2Health News:Resilin Protein from Flea can be used for cardiovascular disease 2
Inquire...
The Perfect Single basic Vac Manifold is used to process a single 96-well plate; processing time is approximately 30 minutes....
The Perfect Vac Quad Manifold allows one to four 96-well plates to be processed simultaneously. A single plate may be processed in 30 minutes; four plates are processed in 45 minutes....
... from Caliper provide an automated alternative to Kuderna-Danish, Rotary, Vacuum-Style and Nitrogen Blow-Down Evaporators. For over ten ... today. ... ... ...
Medicine Products: